Filter your results
- 4
- 4
- 3
- 1
- 1
- 2
- 1
- 4
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 4
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
Lorlatinib for advanced ALK and ROS1+non-small cell lung cancer (NSCLC): Efficacy and treatment sequences in the IFCT-1803 LORLATU expanded access program (EAP) cohort.Journal of Clinical Oncology, 2020, 38 (15), ⟨10.1200/JCO.2020.38.15_suppl.9615⟩
Journal articles
hal-03036515v1
|
|||
Primary cardiac sarcomas: A retrospective study of the French Sarcoma Group.European Journal of Cancer, 2013, epub ahead of print. ⟨10.1016/j.ejca.2013.09.012⟩
Journal articles
hal-00875589v1
|
|||
|
Lung cancer in combined pulmonary fibrosis and emphysema: a series of 47 Western patientsJournal of Thoracic Oncology, 2014, 9 (8), pp.1162--1170. ⟨10.1097/JTO.0000000000000209⟩
Journal articles
hal-01063912v1
|
||
Electrochemical access to 8-(1-phenyl-ethyl)-1,4-dioxa-8-aza-spiro[4.5]decane-7-carbonitrile. Application to the asymmetric syntheses of (+)-myrtine and alkaloid (+)-241D.Journal of Organic Chemistry, 2014, 79 (8), pp.3358-73. ⟨10.1021/jo500104c⟩
Journal articles
hal-01116313v1
|